Senseonics Holdings, Inc. Schedules Third Quarter 2016 Earnings Release & Conference Call for November 3, 2016 at 4:30 p.m. E...
October 17 2016 - 4:15PM
Business Wire
Senseonics Holdings, Inc. (NYSE-MKT:SENS) today announced
that it plans to release its third quarter 2016 financial results
after market close on Thursday, November 3, 2016. Management will
hold a conference call to review the company’s third quarter 2016
performance starting at 4:30 p.m. (Eastern Time) on the same day.
The conference call will be concurrently webcast. The link to the
webcast will be available on Senseonics Holdings, Inc. website at
www.senseonics.com by navigating to “Investor Relations,” and then
“Events & Publications,” and will be archived there for future
reference.
To listen to the conference call, please dial (877) 883-0383
(US/Canada) or (412) 902-6506 (International), Participant Elite
Entry Number 1720785, approximately five to ten minutes prior to
start time.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company
focused on the design, development and commercialization of glucose
monitoring products designed to help people with diabetes
confidently live their lives with ease. Senseonics’ first
generation continuous glucose monitoring system, Eversense®,
includes a small sensor, smart transmitter and mobile application.
Based on fluorescence sensing technology, the sensor is designed to
be inserted subcutaneously and communicate with the smart
transmitter to wirelessly transmit glucose levels to a mobile
device. After insertion, the sensor is designed to continually and
accurately measure glucose levels. For more information on
Senseonics, please visit www.senseonics.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161017006463/en/
Senseonics Holdings, Inc.R. Don Elsey, 301-515-7260Chief
Financial Officerdon.elsey@senseonics.com
Senseonics (AMEX:SENS)
Historical Stock Chart
From Jan 2025 to Feb 2025
Senseonics (AMEX:SENS)
Historical Stock Chart
From Feb 2024 to Feb 2025